Literature DB >> 21550765

Dilute betadine lavage before closure for the prevention of acute postoperative deep periprosthetic joint infection.

Nicholas M Brown1, Cara A Cipriano, Mario Moric, Scott M Sporer, Craig J Della Valle.   

Abstract

This study evaluated the efficacy of a dilute Betadine (Purdue Pharma, Stamford, Conn) lavage in preventing early deep postoperative infection after total hip (THA) and knee (TKA) arthroplasty. A protocol of dilute Betadine lavage (0.35%) for 3 minutes was introduced to the practice of the senior author in June 2008. A total of 1862 consecutive cases (630 THA and 1232 TKA) performed before this were compared with 688 consecutive cases (274 THA and 414 TKA) after for the occurrence of periprosthetic infections within the first 90 days postoperatively. Eighteen early postoperative infections were identified before the use of dilute Betadine lavage, and 1 since (0.97% and 0.15%, respectively; P = .04). There were no significant demographic differences between the 2 groups. Betadine lavage before wound closure may be an inexpensive, effective means of reducing acute postoperative infection after total joint arthroplasty.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21550765     DOI: 10.1016/j.arth.2011.03.034

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  41 in total

1.  Do local antibiotics reduce periprosthetic joint infections? A retrospective review of 744 cases.

Authors:  Craig Winkler; Joel Dennison; Adam Wooldridge; Eneko Larumbe; Cyrus Caroom; Mark Jenkins; George Brindley
Journal:  J Clin Orthop Trauma       Date:  2017-08-24

2.  CORR Insights®: What are the Factors Associated With Re-revision After One-stage Revision for Periprosthetic Joint Infection of the Hip? A Case-control Study.

Authors:  Hany Bedair
Journal:  Clin Orthop Relat Res       Date:  2019-10       Impact factor: 4.176

3.  Rare coexistence of gouty and septic arthritis after arthroscopic rotator cuff repair: a case report.

Authors:  Toru Ichiseki; Shusuke Ueda; Tadami Matsumoto
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  CORR Insights®: One-stage Revision With Catheter Infusion of Intraarticular Antibiotics Successfully Treats Infected THA.

Authors:  Antonia F Chen
Journal:  Clin Orthop Relat Res       Date:  2016-08-29       Impact factor: 4.176

5.  Is potential malnutrition associated with septic failure and acute infection after revision total joint arthroplasty?

Authors:  Paul H Yi; Rachel M Frank; Elliott Vann; Kevin A Sonn; Mario Moric; Craig J Della Valle
Journal:  Clin Orthop Relat Res       Date:  2015-01       Impact factor: 4.176

6.  Topical adjuvants incompletely remove adherent Staphylococcus aureus from implant materials.

Authors:  Emily P Ernest; Anthony S Machi; Brock A Karolcik; Paul R LaSala; Matthew J Dietz
Journal:  J Orthop Res       Date:  2017-11-30       Impact factor: 3.494

7.  Topical vancomycin and its effect on survival and migration of osteoblasts, fibroblasts, and myoblasts: An in vitro study.

Authors:  James X Liu; Dalibel Bravo; John Buza; Thorsten Kirsch; Oran Kennedy; Andrew Rokito; Joseph D Zuckerman; Mandeep S Virk
Journal:  J Orthop       Date:  2018-01-30

8.  CORR Insights®: Partially Melted Ti6Al4V Particles Increase Bacterial Adhesion and Inhibit Osteogenic Activity on 3D-printed Implants: An In Vitro Study.

Authors:  Jonathan P Garino
Journal:  Clin Orthop Relat Res       Date:  2019-12       Impact factor: 4.176

9.  Reverse shoulder prosthesis to treat complex proximal humeral fractures in the elderly patients: results after 10-year experience.

Authors:  R Russo; G Della Rotonda; F Cautiero; M Ciccarelli
Journal:  Musculoskelet Surg       Date:  2015-05-12

Review 10.  Centers for Disease Control and Prevention 2017 Guidelines for Prevention of Surgical Site Infections: Review and Relevant Recommendations.

Authors:  K Keely Boyle; Sridhar Rachala; Scott R Nodzo
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.